Gene: NFKBIE
Official Full Name: NFKB inhibitor epsilonprovided by HGNC
Gene Summary: The protein encoded by this gene binds to components of NF-kappa-B, trapping the complex in the cytoplasm and preventing it from activating genes in the nucleus. Phosphorylation of the encoded protein targets it for destruction by the ubiquitin pathway, which activates NF-kappa-B by making it available to translocate to the nucleus. [provided by RefSeq, Sep 2011]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO36370 | NFKBIE Knockout cell line (HeLa) | Human | NFKBIE | 1:3~1:6 | Negative | Online Inquiry |
KO36371 | NFKBIE Knockout cell line (HCT 116) | Human | NFKBIE | 1:2~1:4 | Negative | Online Inquiry |
KO36372 | NFKBIE Knockout cell line (HEK293) | Human | NFKBIE | 1:3~1:6 | Negative | Online Inquiry |
KO36373 | NFKBIE Knockout cell line (A549) | Human | NFKBIE | 1:3~1:4 | Negative | Online Inquiry |
NFKBIE Gene Knockout Cell Lines are genetically engineered cell lines specifically designed to disrupt the expression of the NFKBIE gene, which encodes for a protein that plays a critical role in modulating the NF-kB signaling pathway. This pathway is essential for regulating diverse biological processes, including immune responses, inflammation, and cell survival. The knockout of NFKBIE allows researchers to investigate the unregulated activity of NF-kB, providing insights into its role in various pathophysiological conditions such as cancer, autoimmune diseases, and chronic inflammatory disorders.
These cell lines function by creating a loss-of-function model, whereby the absence of NFKBIE expression enhances the understanding of NF-kB-mediated gene transcription. This mechanistic clarity can lead to the identification of novel therapeutic targets and the validation of new drug candidates designed to modulate NF-kB activity. Importantly, NFKBIE gene knockout cell lines have widespread applications in both basic research and clinical settings, facilitating studies aimed at deciphering the complex interplay between inflammation and cancer progression, as well as other diseases characterized by dysregulated NF-kB signaling.
What sets our NFKBIE Gene Knockout Cell Lines apart from competitors is the precision of our gene editing techniques and the stability of the resulting cell lines, ensuring reproducibility and reliability in experimental outcomes. Moreover, these knockout lines are readily accessible for high-throughput screening applications, making them an invaluable resource for pharmaceutical companies and academic institutions aiming to accelerate drug discovery and development processes.
For researchers and clinicians, the ability to dynamically study the effects of NF-kB activation versus repression in a controlled environment opens new avenues for innovative research. This product not only fosters groundbreaking discoveries but also supports the translation of findings from the bench to the bedside, ultimately enhancing patient care.
Our company prides itself on its expertise in molecular biology and genetic engineering, consistently delivering high-quality biological products tailored to meet the evolving needs of the scientific community. Our commitment to innovation and excellence ensures that our clients have access to cutting-edge tools for their research endeavors.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.